| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-07 | 5,904 | $9.98 | $58.92kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-03 | 22,429 | $9.49 | $212.85kSell |
| Mark J. Casey | EVP Chief Legal Officer | 2026-03-03 | 11,378 | $9.49 | $107.98kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| John C. Jacobs | President and CEO | 2026-03-03 | 69,288 | $9.49 | $657.54kSell |
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-03 | 20,850 | $9.49 | $197.87kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-01 | 10,969 | $10.14 | $111.23kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Shah Capital Management | 9.03% | 14,845,097 | $113.71M | Institution |
| Blackrock Inc | 7.81% | 12,844,319 | $98.39M | Institution |
| Cadila Pharmaceuticals Ltd | 5.78% | 9,500,000 | $72.77M | Insider |
| State Street Corp | 5.46% | 8,970,518 | $68.71M | Institution |
| D E Shaw Co Inc | 4.69% | 7,709,858 | $59.06M | Institution |
| Vanguard Portfolio Management LLC | 4.35% | 7,151,625 | $54.78M | Institution |
| Vanguard Capital Management LLC | 4.34% | 7,130,147 | $54.62M | Institution |
| Sanofi | 4.18% | 6,880,481 | $52.70M | Institution |
| Bank Of America Corp | 4.04% | 6,637,213 | $50.84M | Institution |
| James B. 1. Tananbaum | 3.81% | 6,268,455 | $48.02M | Insider |